Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| As we have said, our profitability and cash flow will continue to grow faster than revenue |
| Our fourth quarter was a strong end to a solid year in every area of the business, compliance, supply chain and traceability |
| You heard John describe the 7% growth in recurring revenue, continued expense management, a 40% increase in GAAP profitability, and a 50-plus percent growth in earnings per share |
| RTN revenue in 2023 was better than we expected given our expectation frankly of zero |
| So, the truth is we’ve developed really, really good relationships with our customers |
| We believe RTN revenue will accelerate in calendar 2024 |
| We have a well-defined process and an amazing team of people holding our customers’ hands as we lead them down the road to FDA compliance |
| Traceability is better for me and better for my customers |
| Our core business is structurally profitable in generating very significant cash |
| Our compliance and supply chain business continues to gain momentum for the year, despite overcoming $700,000 of the high-touch, non-core revenue we de-emphasized that I previously mentioned |
| So far, as you’ve heard from John’s review of the quarterly and full-year metrics, these decisions have demonstrated excellent financial results |
| As I said earlier, our core compliance and supply chain business continue to grow efficiently and profitably |
| Our industry presence, including our customer relationships, our industry endorsements, the advisory committee, create a durable, very significant competitive advantage for our ReposiTrak Traceability Network, or as we call it RTN |
| Our customers are priority one and we can deliver superior customer service while at the same time increasing our profitability |
| So we’re reasonably confident that the FDA will go -- let’s give everybody an extra year |
| The compliance model gives us tremendous credibility in the industry |
| So the net result of that should be faster revenue growth, even faster net income growth, and faster yet earnings per share growth |
| We continue to gain momentum in the growth of recurring revenue, delivering 80 plus percent gross margin, double digit EPS growth |
| So a 6% increase in recurring revenue generated a 46% increase in the bottom line this year, even as we invested heavily in RTN |
| Our trade associations are becoming more vocal in their support for our efforts so at this point we’re not just optimistic but really pleased with the industry position that we have in traceability |
| GAAP net income increased year-over-year by 26% |
| You are seeing that today as we grew revenue by 6% and net income by 40% |
| We are confident that traceability will begin to generate meaningful revenue in calendar 2024 |
| We built a consistent cash generation machine with six consecutive years of real GAAP profitability |
| Take care of the customer, grow recurring revenue, rationalizing costs with the opportunity of future revenues, control costs, increase net income, accelerate EPS, buy back shares, which now includes the preferred shares and drive cash |
| Recurring revenue for the same period grew 7% from $17.8 million to $19 million |
| So calendar 24 will be excellent and 25 will likely be a crush |
| But we are confident that we are the component, the key component, to make industry-wide traceability work in a cost-effective manner |
| Earnings per share increased 52% for the year to $0.27 per share and increased 34% for the June quarter to $0.07 |
| So it’s good for the customer and it certainly helps us spread the word |
| Statement |
|---|
| Not positive it’s going to happen |
| Doing it is very difficult |
| I’m not positive |
| So, new logistic complications like Rule 204 are frankly a disaster |
| I believe the momentum we are seeing initially with traceability customers faster than I anticipated will only accelerate |
| This requires us to continue to make difficult decisions to drive high margin incremental revenue while keeping costs in line and driving profitability and cash |
| I’m having some phone issues |
| People who are conservative want to start now because it is a bigger problem than they thought |
| Their business is based on speed and inaccuracy and frankly, lack of complication is critical to their success |
| And we have to keep our heads down doing that |
| Park City Group remarks are subject to risks and uncertainties which actual results could differ materially |
| It will not enable people to be compliant with labeling alone |
| It’s longer than that, and it’s difficult to do |
| In every respect, it is difficult to do |
| And the problem that we worry about is having to say to a customer God, we talked to you two years ago and you said you thought you could get it done in a year and now you’re calling us and you want us to get it done in six months? Can’t happen |
| An obvious question though for investors is how does the RTN initiative affect our operating costs? Simple |
| You’ll also note we have reduced our capitalization by over 10% through the repurchase and retirement of shares since we initiated our stock buyback plan |
Please consider a small donation if you think this website provides you with relevant information